Additionally, aromatase inhibitors are more effective than tamoxifen in preventing the recurrence of breast cancer, particularly in cases where the cancer is positive for oestrogen and/or progesterone receptors [29,30]. The gene discussed is CYP19A1; the disease is breast carcinoma.